Gladstone Institutional Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
23,375
+2,998
+15% +$242K 0.06% 308
2026
Q1
$1.77M Sell
20,377
-862
-4% -$82.6K 0.07% 282
2025
Q4
$2.04M Buy
21,239
+379
+2% +$36.8K 0.08% 250
2025
Q3
$1.99M Buy
20,860
+248
+1% +$22.8K 0.08% 248
2025
Q2
$1.8M Buy
20,612
+154
+0.8% +$13.1K 0.07% 253
2025
Q1
$1.84M Sell
20,458
-2,737
-12% -$245K 0.09% 240
2024
Q4
$1.85M Sell
23,195
-3,846
-14% -$333K 0.09% 234
2024
Q3
$2.43M Sell
27,041
-20,663
-43% -$1.74M 0.12% 194
2024
Q2
$3.75M Buy
47,704
+2,405
+5% +$197K 0.2% 141
2024
Q1
$3.95M Buy
45,299
+16,093
+55% +$1.37M 0.22% 127
2023
Q4
$2.41M Sell
29,206
-144
-0.5% -$11K 0.13% 187
2023
Q3
$2.3M Sell
29,350
-6,121
-17% -$512K 0.15% 174
2023
Q2
$3.12M Buy
35,471
+8,384
+31% +$722K 0.19% 135
2023
Q1
$2.18M Buy
27,087
+4,243
+19% +$346K 0.14% 183
2022
Q4
$1.78M Sell
22,844
-3,352
-13% -$272K 0.13% 198
2022
Q3
$2.12M Sell
26,196
-457
-2% -$41.1K 0.17% 158
2022
Q2
$2.39M Sell
26,653
-1,575
-6% -$160K 0.19% 139
2022
Q1
$3.13M Sell
28,228
-15,744
-36% -$1.66M 0.21% 123
2021
Q4
$4.55M Buy
43,972
+11,862
+37% +$1.37M 0.35% 79
2021
Q3
$4.03M Buy
32,110
+21,780
+211% +$2.82M 0.39% 70
2021
Q2
$1.28M Buy
10,330
+6,691
+184% +$840K 0.15% 158
2021
Q1
$430K Buy
+3,639
New +$426K 0.07% 256
2020
Q2
Sell
-4,245
Closed -$383K 279
2020
Q1
$383K Buy
4,245
+1,046
+33% +$111K 0.1% 162
2019
Q4
$363K Sell
3,199
-831
-21% -$91.2K 0.09% 169
2019
Q3
$438K Buy
4,030
+93
+2% +$9.7K 0.11% 162
2019
Q2
$383K Buy
+3,937
New +$359K 0.12% 173

Other funds holding MDT

Gladstone Institutional Advisory's MDT Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $242K and bringing the position to 23,375 shares worth $1.83M. The position accounts for 0.06% of the portfolio, ranked #308.

Gladstone Institutional Advisory first reported a position in MDT in Q2 2019 and has held it in 26 quarters since. The position peaked at $4.55M in Q4 2021. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Gladstone Institutional Advisory held 23,375 shares of Medtronic worth $1.83M as of Q2 2026.
  • Gladstone Institutional Advisory bought 2,998 Medtronic shares in Q2 2026, an estimated $242K.
  • Medtronic made up 0.06% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #308 holding.
  • Gladstone Institutional Advisory first reported a position in Medtronic in Q2 2019 and has held it in 26 quarters since.
  • Gladstone Institutional Advisory's Medtronic position peaked at $4.55M in Q4 2021.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.